Literature DB >> 31700504

Procoagulant Activity of Red Blood Cell-Derived Microvesicles during Red Cell Storage.

Akbar Hashemi Tayer1,2, Naser Amirizadeh2, Minoo Ahmadinejad3, Mahin Nikougoftar2, Mohammad Reza Deyhim2, Sima Zolfaghari2.   

Abstract

BACKGROUND: Red blood cells (RBCs) undergo structural and biochemical alterations during storage which are collectively called RBC storage lesion and cause a decrease in RBC recovery and survival. During storage, erythrocytes release an increasing number of microvesicles (MVs) that have key roles in biological processes. We aimed to investigate the procoagulant activity (PCA) of RBC-derived MVs during storage.
METHODS: 20 packed RBCs were stored for up to 42 days. Samples were taken at seven different times and evaluated for the presence of RBC-MVs. MVs were separated, and following filtration flow cytometry was used to characterize RBC-MVs based on the expression of glycophorin A (Gly.A) and annexin V (AnnV) antigens. The coagulant activity of RBC-MVs was tested by clotting time (CT) and PCA assays. Results were compared before and after filtration.
RESULTS: Flow cytometry revealed a 17.6-fold increase in RBC-MVs after 6 weeks of storage. Significant correlations were found between AnnV+ MVs and PCA (r = 0.96; p < 0.001), and CT (r = -0.77; p < 0.001) which was associated with increased PCA and shortened CT with RBC aging. Filtration of samples efficiently removed MVs (p < 0.001) and also reduced in vitro PCA of MVs (p < 0.001).
CONCLUSION: RBC-MVs are procoagulant (particularly AnnV+ MVs) Reduction of MVs from RBC concentrates may reduce the risk of transfusion-induced thrombotic complications.
Copyright © 2018 by S. Karger AG, Basel.

Entities:  

Keywords:  Filtration; Microvesicles; Procoagulant activity; Red blood cell storage

Year:  2018        PMID: 31700504      PMCID: PMC6739704          DOI: 10.1159/000494367

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN: 1660-3796            Impact factor:   3.747


  28 in total

1.  Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol.

Authors:  R Lacroix; C Judicone; P Poncelet; S Robert; L Arnaud; J Sampol; F Dignat-George
Journal:  J Thromb Haemost       Date:  2012-03       Impact factor: 5.824

2.  Flow cytometric analysis of microparticle phenotype and their role in thrombin generation.

Authors:  M G Macey; N Enniks; S Bevan
Journal:  Cytometry B Clin Cytom       Date:  2011-01       Impact factor: 3.058

3.  Erythrocyte vesiculation: a self-protective mechanism?

Authors:  Frans L A Willekens; Jan M Werre; Yvonne A M Groenen-Döpp; Bregt Roerdinkholder-Stoelwinder; Ben de Pauw; Giel J C G M Bosman
Journal:  Br J Haematol       Date:  2008-05       Impact factor: 6.998

4.  Phosphatidylserine exposure on stored red blood cells as a parameter for donor-dependent variation in product quality.

Authors:  Sip Dinkla; Malou Peppelman; Jori Van Der Raadt; Femke Atsma; Vera M J Novotný; Marian G J Van Kraaij; Irma Joosten; Giel J C G M Bosman
Journal:  Blood Transfus       Date:  2013-10-03       Impact factor: 3.443

5.  Detection of microparticles from human red blood cells by multiparametric flow cytometry.

Authors:  Giulia Grisendi; Elena Finetti; Daniele Manganaro; Nicoletta Cordova; Giuliano Montagnani; Carlotta Spano; Malvina Prapa; Valentina Guarneri; Satoru Otsuru; Edwin M Horwitz; Giorgio Mari; Massimo Dominici
Journal:  Blood Transfus       Date:  2014-10-23       Impact factor: 3.443

6.  Microparticle counts in platelet-rich and platelet-free plasma, effect of centrifugation and sample-processing protocols.

Authors:  Wayne L Chandler
Journal:  Blood Coagul Fibrinolysis       Date:  2013-03       Impact factor: 1.276

7.  Analysis of leucocyte antibodies, cytokines, lysophospholipids and cell microparticles in blood components implicated in post-transfusion reactions with dyspnoea.

Authors:  K Maślanka; M Uhrynowska; P Łopacz; A Wróbel; G Smoleńska-Sym; K Guz; E Lachert; A Ostas; E Brojer
Journal:  Vox Sang       Date:  2014-08-18       Impact factor: 2.144

Review 8.  Red blood cell-derived microparticles: An overview.

Authors:  Maxwell Westerman; John B Porter
Journal:  Blood Cells Mol Dis       Date:  2016-04-13       Impact factor: 3.039

9.  Microparticle-associated tissue factor activity: a link between cancer and thrombosis?

Authors:  M E T Tesselaar; F P H T M Romijn; I K Van Der Linden; F A Prins; R M Bertina; S Osanto
Journal:  J Thromb Haemost       Date:  2006-12-13       Impact factor: 5.824

10.  Erythrocyte-derived microparticles supporting activated protein C-mediated regulation of blood coagulation.

Authors:  Ruzica Livaja Koshiar; Sofia Somajo; Eva Norström; Björn Dahlbäck
Journal:  PLoS One       Date:  2014-08-19       Impact factor: 3.240

View more
  14 in total

1.  Red blood cell microvesicles activate the contact system, leading to factor IX activation via 2 independent pathways.

Authors:  Denis F Noubouossie; Michael W Henderson; Micah Mooberry; Anton Ilich; Patrick Ellsworth; Mark Piegore; Sarah C Skinner; Rafal Pawlinski; Ian Welsby; Thomas Renné; Maureane Hoffman; Dougald M Monroe; Nigel S Key
Journal:  Blood       Date:  2020-03-05       Impact factor: 22.113

2.  The potential effect of leukocyte filtration methods on erythrocyte-derived microvesicles: One step forward.

Authors:  Fateme Roshanzamir; Sedigheh Amini-Kafiabad; Mahin Nikougoftar Zarif; Ali Arabkhazaeli; Mahshid Mohammadipour
Journal:  Eur J Transl Myol       Date:  2022-08-01

3.  Responses of human colon and breast adenocarcinoma cell lines (LoVo, MCF7) and non-tumorigenic mammary epithelial cells (MCF-10A) to the acellular fraction of packed red blood cells in the presence and absence of cisplatin.

Authors:  Kamila Czubak-Prowizor; Anna Macieja; Tomasz Poplawski; Halina Malgorzata Zbikowska
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

Review 4.  Blood Cell-Derived Microvesicles in Hematological Diseases and beyond.

Authors:  Hara T Georgatzakou; Sotirios P Fortis; Effie G Papageorgiou; Marianna H Antonelou; Anastasios G Kriebardis
Journal:  Biomolecules       Date:  2022-06-08

5.  Quantifying dynamic range in red blood cell energetics: Evidence of progressive energy failure during storage.

Authors:  Stephen C Rogers; Xia Ge; Mary Brummet; Xue Lin; David D Timm; Andre d'Avignon; Joel R Garbow; Jeff Kao; Jaya Prakash; Aaron Issaian; Elan Z Eisenmesser; Julie A Reisz; Angelo D'Alessandro; Allan Doctor
Journal:  Transfusion       Date:  2021-04-08       Impact factor: 3.157

Review 6.  Membrane Microvesicles as Potential Vaccine Candidates.

Authors:  Layaly Shkair; Ekaterina E Garanina; Robert J Stott; Toshana L Foster; Albert A Rizvanov; Svetlana F Khaiboullina
Journal:  Int J Mol Sci       Date:  2021-01-24       Impact factor: 5.923

Review 7.  Innate Immunity Communicates Using the Language of Extracellular Microvesicles.

Authors:  Mariusz Z Ratajczak; Janina Ratajczak
Journal:  Stem Cell Rev Rep       Date:  2021-02-25       Impact factor: 5.739

Review 8.  Extracellular Vesicles from Red Blood Cells and Their Evolving Roles in Health, Coagulopathy and Therapy.

Authors:  Kiruphagaran Thangaraju; Sabari Nath Neerukonda; Upendra Katneni; Paul W Buehler
Journal:  Int J Mol Sci       Date:  2020-12-25       Impact factor: 5.923

Review 9.  Extracellular microvesicles/exosomes: discovery, disbelief, acceptance, and the future?

Authors:  Mariusz Z Ratajczak; Janina Ratajczak
Journal:  Leukemia       Date:  2020-09-14       Impact factor: 11.528

10.  Storage conditions determine the characteristics of red blood cell derived extracellular vesicles.

Authors:  Tímea Bebesi; Diána Kitka; Anikó Gaál; Imola Csilla Szigyártó; Róbert Deák; Tamás Beke-Somfai; Kitti Koprivanacz; Tünde Juhász; Attila Bóta; Zoltán Varga; Judith Mihály
Journal:  Sci Rep       Date:  2022-01-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.